Multiple-dose pharmacokinetics, safety and tolerability of aprocitentan, a dual endothelin receptor antagonist, in healthy Japanese and Caucasian subjects

Authors
Category Primary study
ConferenceClinical Pharmacology in Drug Development
Year 2020
This article has no abstract
Epistemonikos ID: c8e6eee795a7f75e94d43b92c6848f87f5bf79b4
First added on: Apr 30, 2026